{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:28:01Z","timestamp":1773271681076,"version":"3.50.1"},"reference-count":92,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.4065\/83.10.1116","type":"journal-article","created":{"date-parts":[[2009,1,24]],"date-time":"2009-01-24T00:58:09Z","timestamp":1232758689000},"page":"1116-1130","source":"Crossref","is-referenced-by-count":76,"title":["Development of Peripheral Opioid Antagonists: New Insights Into Opioid Effects"],"prefix":"10.4065","volume":"83","author":[{"given":"Jonathan","family":"Moss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl E.","family":"Rosow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.4065\/83.10.1116_bib1","first-page":"189","article-title":"The isolation of morphine: first principles in science and ethics","volume":"1","author":"Huxtable","year":"2001","journal-title":"Mol Interv"},{"issue":"6","key":"10.4065\/83.10.1116_bib2","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1345\/aph.1K009","article-title":"Methylnaltrexone mechanisms of action and effects on opioid bowel dysfunction and other opioid adverse effects","volume":"41","author":"Yuan","year":"2007","journal-title":"Ann Pharmacother"},{"key":"10.4065\/83.10.1116_bib3","first-page":"175","article-title":"Pain relief without side effects: peripheral opiate antagonists","volume":"Vol 33","author":"Moss","year":"2005"},{"issue":"2","key":"10.4065\/83.10.1116_bib4","first-page":"CD006332","article-title":"Mu-opioid antagonists for opioid-induced bowel dysfunction","author":"McNicol","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.4065\/83.10.1116_bib5","series-title":"FDA approves Relistor for opioid-induced constipation [press release]","author":"US Food and Drug Administration","year":"2008"},{"key":"10.4065\/83.10.1116_bib6","series-title":"FDA approves Entereg to help restore bowel function following surgery [press release]","author":"US Food and Drug Administration","year":"2008"},{"issue":"7","key":"10.4065\/83.10.1116_bib7","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2165\/00003495-200363070-00003","article-title":"Opioid-induced bowel dysfunction: pathophysiology and potential new therapies","volume":"63","author":"Kurz","year":"2003","journal-title":"Drugs"},{"issue":"10","key":"10.4065\/83.10.1116_bib8","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/j.1552-4604.1998.tb04389.x","article-title":"Gut motility and transit changes in patients receiving long-term methadone maintenance","volume":"38","author":"Yuan","year":"1998","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"10.4065\/83.10.1116_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0304-3959(84)90121-0","article-title":"Oral morphine in chronic cancer pain","volume":"18","author":"Walsh","year":"1984","journal-title":"Pain"},{"issue":"4","key":"10.4065\/83.10.1116_bib10","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00002820-199808000-00011","article-title":"Side effects of morphine administration in cancer patients","volume":"21","author":"Vanegas","year":"1998","journal-title":"Cancer Nurs"},{"issue":"5","key":"10.4065\/83.10.1116_bib11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1191\/026921698674125048","article-title":"The relationship between opioid use and laxative use in terminally ill cancer patients","volume":"12","author":"Sykes","year":"1998","journal-title":"Palliat Med"},{"issue":"5A suppl","key":"10.4065\/83.10.1116_bib12","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.1016\/S0002-9610(01)00782-6","article-title":"Incidence, prevalence, and management of opioid bowel dysfunction","volume":"182","author":"Pappagallo","year":"2001","journal-title":"Am J Surg"},{"key":"10.4065\/83.10.1116_bib13","series-title":"Oxford Textbook of Palliative Medicine","first-page":"483","article-title":"Constipation and diarrhoea","author":"Sykes","year":"2004"},{"issue":"1","key":"10.4065\/83.10.1116_bib14","first-page":"61","article-title":"Current management of opioid-related side effects","volume":"15","author":"O'Mahony","year":"2001","journal-title":"Oncology (Williston Park)"},{"key":"10.4065\/83.10.1116_bib15","series-title":"Sleisenger & Fordtran's Gastrointestinal and Liver Disease","first-page":"2863","article-title":"Palliative medicine in patients with advanced gastrointestinal and hepatic disease","author":"Marr","year":"2006"},{"key":"10.4065\/83.10.1116_bib16","first-page":"A1490","article-title":"Opioid-induced constipation compromises pain management and impacts patient quality of life [abstract A1490]","volume":"105","author":"Leslie","year":"2006","journal-title":"Anesthesiology"},{"issue":"3","key":"10.4065\/83.10.1116_bib17","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1046\/j.1526-4637.2002.02045.x","article-title":"Utility assessments of opioid treatment for chronic pain","volume":"3","author":"Schmier","year":"2002","journal-title":"Pain Med"},{"issue":"5A suppl","key":"10.4065\/83.10.1116_bib18","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/S0002-9610(01)00781-4","article-title":"Review of postoperative ileus","volume":"182","author":"Kehlet","year":"2001","journal-title":"Am J Surg"},{"issue":"1","key":"10.4065\/83.10.1116_bib19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/MJT.0b013e31804c6f37","article-title":"New therapies in the treatment of postoperative ileus after gastrointestinal surgery","volume":"15","author":"Maron","year":"2008","journal-title":"Am J Ther"},{"issue":"16","key":"10.4065\/83.10.1116_bib20","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/0024-3205(85)90187-0","article-title":"Selective presence of opiate receptors on intestinal circular muscle cells","volume":"37","author":"Bitar","year":"1985","journal-title":"Life Sci"},{"issue":"1","key":"10.4065\/83.10.1116_bib21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0885-3924(02)00424-4","article-title":"Opioid antagonists: a review of their role in palliative care, focusing on use in opioid-related constipation","volume":"24","author":"Choi","year":"2002","journal-title":"J Pain Symptom Manage"},{"issue":"2, pt 1","key":"10.4065\/83.10.1116_bib22","first-page":"G224","article-title":"Sites of action of \u03bc-, \u03ba- and \u03c3-opiate receptor agonists at the feline ileocecal sphincter","volume":"254","author":"Ouyang","year":"1988","journal-title":"Am J Physiol"},{"key":"10.4065\/83.10.1116_bib23","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1146\/annurev.pa.25.040185.001341","article-title":"The central and peripheral influences of opioids on gastrointestinal propulsion","volume":"25","author":"Manara","year":"1985","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"2","key":"10.4065\/83.10.1116_bib24","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0022-3565(25)11008-2","article-title":"Peptide opioid antagonist separates peripheral and central opioid antitransit effects","volume":"243","author":"Shook","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.4065\/83.10.1116_bib25","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0022-3565(25)24947-3","article-title":"Inhibition of gastrointestinal transit by morphine in rats results primarily from direct drug action on gut opioid sites","volume":"237","author":"Manara","year":"1986","journal-title":"J Pharmacol Exp Ther"},{"key":"10.4065\/83.10.1116_bib26","series-title":"Handbook of Equine Colic","author":"White","year":"1999"},{"issue":"2","key":"10.4065\/83.10.1116_bib27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF03010654","article-title":"Naloxone infusion after prophylactic epidural morphine: effects on incidence of postoperative side-effects and quality of analgesia","volume":"35","author":"Gowan","year":"1988","journal-title":"Can J Anaesth"},{"issue":"1","key":"10.4065\/83.10.1116_bib28","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/clpt.1992.106","article-title":"Treatment of opioid-induced constipation with oral naloxone: a pilot study","volume":"52","author":"Culpepper-Morgan","year":"1992","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.4065\/83.10.1116_bib29","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0376-8716(95)01153-P","article-title":"Assessment of nalmefene glucuronide as a selective gut opioid antagonist","volume":"39","author":"Cheskin","year":"1995","journal-title":"Drug Alcohol Depend"},{"key":"10.4065\/83.10.1116_bib30","series-title":"Handbook of Opioid Bowel Syndrome","first-page":"175","article-title":"Using oral naloxone in management of opioid bowel dysfunction","author":"Sykes","year":"2005"},{"issue":"3","key":"10.4065\/83.10.1116_bib31","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0028-3908(85)90072-3","article-title":"The use of quaternary narcotic antagonists in opiate research","volume":"24","author":"Brown","year":"1985","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.4065\/83.10.1116_bib32","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0014-2999(82)90026-7","article-title":"Antagonism of gut, but not central effects of morphine with quaternary narcotic antagonists","volume":"78","author":"Russell","year":"1982","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.4065\/83.10.1116_bib33","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0022-3565(25)38820-8","article-title":"Independent central and peripheral mediation of morphine-induced inhibition of gastrointestinal transit in rats","volume":"236","author":"Gmerek","year":"1986","journal-title":"J Pharmacol Exp Ther"},{"issue":"1\u20132","key":"10.4065\/83.10.1116_bib34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0014-2999(95)00018-G","article-title":"Effects of methylnaltrexone on morphine-induced inhibition of contraction in isolated guinea-pig ileum and human intestine","volume":"276","author":"Yuan","year":"1995","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.4065\/83.10.1116_bib35","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1001\/jama.283.3.367","article-title":"Methylnaltrexone for reversal of constipation due to chronic methadone use: a randomized controlled trial","volume":"283","author":"Yuan","year":"2000","journal-title":"JAMA"},{"issue":"4","key":"10.4065\/83.10.1116_bib36","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1067\/mcp.2000.105037","article-title":"Effects of enteric coated methylnaltrexone in preventing opioid-induced delay in oral-cecal transit time","volume":"67","author":"Yuan","year":"2000","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"10.4065\/83.10.1116_bib37","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1177\/0091270004273491","article-title":"Tolerability, gut effects, and pharmacokinetics of methylnaltrexone following repeated intravenous administration in humans","volume":"45","author":"Yuan","year":"2005","journal-title":"J Clin Pharmacol"},{"issue":"11","key":"10.4065\/83.10.1116_bib38","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.3109\/00498258909043176","article-title":"Variations in demethylation of N-methylnaltrexone in mice, rats, dogs, and humans","volume":"19","author":"Kotake","year":"1989","journal-title":"Xenobiotica"},{"issue":"4","key":"10.4065\/83.10.1116_bib39","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0009-9236(96)90117-4","article-title":"Methylnaltrexone prevents morphine-induced delay in oral-cecal transit time without affecting analgesia: a double-blind randomized placebo-controlled trial","volume":"59","author":"Yuan","year":"1996","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"10.4065\/83.10.1116_bib40","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1213\/00000539-199404000-00015","article-title":"Efficacy of methylnaltrexone versus naloxone for reversal of morphine-induced depression of hypoxic ventilatory response","volume":"78","author":"Amin","year":"1994","journal-title":"Anesth Analg"},{"issue":"1","key":"10.4065\/83.10.1116_bib41","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1124\/jpet.300.1.118","article-title":"Effects of subcutaneous methylnaltrexone on morphine-induced peripherally mediated side effects: a double-blind randomized placebo-controlled trial","volume":"300","author":"Yuan","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10.4065\/83.10.1116_bib42","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0009-9236(97)90197-1","article-title":"The safety and efficacy of oral methylnaltrexone in preventing morphine-induced delay in oral-cecal transit time","volume":"61","author":"Yuan","year":"1997","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"10.4065\/83.10.1116_bib43","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0304-3959(99)00162-1","article-title":"Effects of intravenous methylnaltrexone on opioid-induced gut motility and transit time changes in subjects receiving chronic methadone therapy: a pilot study","volume":"83","author":"Yuan","year":"1999","journal-title":"Pain"},{"issue":"11","key":"10.4065\/83.10.1116_bib44","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1001\/jama.284.11.1383","article-title":"Oral methylnaltrexone for opioid-induced constipation [letter]","volume":"284","author":"Yuan","year":"2000","journal-title":"JAMA"},{"issue":"5","key":"10.4065\/83.10.1116_bib45","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jpainsymman.2007.12.005","article-title":"Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study","volume":"35","author":"Portenoy","year":"2008","journal-title":"J Pain Symptom Manage"},{"issue":"16S, pt 1 of 2","key":"10.4065\/83.10.1116_bib46","doi-asserted-by":"crossref","first-page":"8003","DOI":"10.1200\/jco.2005.23.16_suppl.lba8003","article-title":"A phase III double-blind placebo-controlled trial of methylnaltrexone (MNTX) for opioid-induced constipation (OIC) in advanced medical illness (AMI) [abstract 8003]","volume":"23","author":"Thomas","year":"2005","journal-title":"J Clin Oncol"},{"issue":"May 20 suppl","key":"10.4065\/83.10.1116_bib47","doi-asserted-by":"crossref","first-page":"9626","DOI":"10.1200\/jco.2008.26.15_suppl.9626","article-title":"Analysis of response to methylnaltrexone by response to previous dose in advanced illness patients with opioid-induced constipation [abstract 9626]","volume":"26","author":"Thomas","year":"2008","journal-title":"J Clin Oncol"},{"issue":"22","key":"10.4065\/83.10.1116_bib48","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1056\/NEJMoa0707377","article-title":"Methylnaltrexone for opioid-induced constipation in advanced illness","volume":"358","author":"Thomas","year":"2008","journal-title":"N Engl J Med"},{"issue":"22","key":"10.4065\/83.10.1116_bib49","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1056\/NEJMe0801783","article-title":"Opioid side effects-mechanism-based therapy [editorial]","volume":"358","author":"Berde","year":"2008","journal-title":"N Engl J Med"},{"key":"10.4065\/83.10.1116_bib50","series-title":"Wyeth and Progenics announce preliminary clinical trial results for Relistor oral and intravenous formulations [press release]","year":"2008"},{"key":"10.4065\/83.10.1116_bib51","first-page":"A893","article-title":"A double-blind, randomized, placebo-controlled trial of methylnaltrexone (MNTX) for post-operative bowel dysfunction in segmental colectomy patients [abstract A893]","volume":"103","author":"Viscusi","year":"2005","journal-title":"Anesthesiology"},{"issue":"1\u20133","key":"10.4065\/83.10.1116_bib52","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejphar.2005.08.008","article-title":"[(3)H]Alvimopan binding to the micro opioid receptor: comparative binding kinetics of opioid antagonists","volume":"520","author":"Cassel","year":"2005","journal-title":"Eur J Pharmacol"},{"issue":"15","key":"10.4065\/83.10.1116_bib53","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1021\/jm00041a003","article-title":"Discovery of a potent, peripherally selective trans-3,4-dimethyl-4-(3-hydroxyphenyl) piperidine opioid antagonist for the treatment of gastrointestinal motility disorders","volume":"37","author":"Zimmerman","year":"1994","journal-title":"J Med Chem"},{"issue":"5A suppl","key":"10.4065\/83.10.1116_bib54","doi-asserted-by":"crossref","first-page":"27S","DOI":"10.1016\/S0002-9610(01)00784-X","article-title":"Alvimopan (ADL 8-2698) is a novel peripheral opioid antagonist","volume":"182","author":"Schmidt","year":"2001","journal-title":"Am J Surg"},{"issue":"5","key":"10.4065\/83.10.1116_bib55","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/sj.clpt.6100292","article-title":"Pharmacokinetics of alvimopan and its metabolite in healthy volunteers and patients in postoperative ileus trials","volume":"83","author":"Foss","year":"2008","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.4065\/83.10.1116_bib56","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1067\/mcp.2001.112680","article-title":"ADL 8-2698, a trans-3,4-dimethyl-4-(3-hydroxyphenyl) piperidine, prevents gastrointestinal effects of intravenous morphine without affecting analgesia","volume":"69","author":"Liu","year":"2001","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"10.4065\/83.10.1116_bib57","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S1542-3565(05)00434-9","article-title":"Effect of alvimopan and codeine on gastrointestinal transit: a randomized controlled study","volume":"3","author":"Gonenne","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"13","key":"10.4065\/83.10.1116_bib58","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1056\/NEJMoa010564","article-title":"Selective postoperative inhibition of gastrointestinal opioid receptors","volume":"345","author":"Taguchi","year":"2001","journal-title":"N Engl J Med"},{"issue":"4","key":"10.4065\/83.10.1116_bib59","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1097\/01.sla.0000141158.27977.66","article-title":"Alvimopan Postoperative Ileus Study Group. Alvimopan, a novel, peripherally acting \u03bc opioid antagonist: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial of major abdominal surgery and postoperative ileus","volume":"240","author":"Wolff","year":"2004","journal-title":"Ann Surg"},{"issue":"6","key":"10.4065\/83.10.1116_bib60","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1007\/s10350-005-0035-7","article-title":"Phase III trial of alvimopan, a novel, peripherally acting, mu opioid antagonist, for postoperative ileus after major abdominal surgery","volume":"48","author":"Delaney","year":"2005","journal-title":"Dis Colon Rectum"},{"key":"10.4065\/83.10.1116_bib61","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1365-2036.2008.03696.x","article-title":"Clinical trial: alvimopan for the management of post-operative ileus after abdominal surgery: results of an international randomized, double-blind, multicentre, placebo-controlled clinical study","volume":"28","author":"B\u00fcchler","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.4065\/83.10.1116_bib62","series-title":"Gastrointestinal Drugs Advisory Committee Meeting","year":"2008"},{"issue":"1","key":"10.4065\/83.10.1116_bib63","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s00464-005-0104-y","volume":"20","author":"Viscusi","year":"2006","journal-title":"Surg Endosc"},{"issue":"3","key":"10.4065\/83.10.1116_bib64","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jpain.2004.12.001","article-title":"Alvimopan: an oral, peripherally acting, \u03bc-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction\u2014a 21-day treatment-randomized clinical trial","volume":"6","author":"Paulson","year":"2005","journal-title":"J Pain"},{"issue":"2","key":"10.4065\/83.10.1116_bib65","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.pain.2007.11.008","volume":"137","author":"Webster","year":"2008","journal-title":"Pain"},{"issue":"4","key":"10.4065\/83.10.1116_bib67","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1097\/00000542-199710000-00008","article-title":"Opioid-induced delay in gastric emptying: a peripheral mechanism in humans","volume":"87","author":"Murphy","year":"1997","journal-title":"Anesthesiology"},{"issue":"11","key":"10.4065\/83.10.1116_bib68","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1177\/009127009803801105","article-title":"Effects of low-dose morphine on gastric emptying in healthy volunteers","volume":"38","author":"Yuan","year":"1998","journal-title":"J Clin Pharmacol"},{"key":"10.4065\/83.10.1116_bib69","unstructured":"Woo M, O'Connor MF, Yuan C-S, Moss J. Reversal of opioid-induced gastric dysfunction in a critically ill burn patient after methylnaltrexone. Anesth Analg. In press."},{"issue":"10","key":"10.4065\/83.10.1116_bib70","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1001\/jama.298.10.1196","article-title":"Management of intractable nausea and vomiting in patients at the end of life: \u201cI was feeling nauseous all of the time \u2026 nothing was working\u201d","volume":"298","author":"Wood","year":"2007","journal-title":"JAMA"},{"issue":"18S suppl, pt 1","key":"10.4065\/83.10.1116_bib71","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1200\/jco.2007.25.18_suppl.4014","article-title":"Effect of alvimopan (ALV) on gastrointestinal (GI) recovery, length of hospital stay (LOS), and postoperative ileus (POI)-related morbidity in patients (PTS) undergoing bowel resection (BR) for colon or rectal cancer (CRC) [abstract 4014]","volume":"25","author":"Weese","year":"2007","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.4065\/83.10.1116_bib72","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0028-3908(98)00192-0","article-title":"Gastric effects of methylnaltrexone on \u03bc, \u03b2, and \u03b4 opioid agonists induced brainstem unitary responses","volume":"38","author":"Yuan","year":"1999","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.4065\/83.10.1116_bib73","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1046\/j.1365-2346.2000.00720.x","article-title":"Patient-controlled analgesia and urinary retention following lower limb joint replacement: prospective audit and logistic regression analysis","volume":"17","author":"O'Riordan","year":"2000","journal-title":"Eur J Anaesthesiol"},{"issue":"1","key":"10.4065\/83.10.1116_bib74","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/sj.clpt.6100164","article-title":"Reversal of opioid-induced bladder dysfunction by intravenous naloxone and methylnaltrexone","volume":"82","author":"Rosow","year":"2007","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.4065\/83.10.1116_bib75","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1476-5381.1988.tb11409.x","article-title":"Effects of codeine, morphine and a novel opioid pentapeptide BW443C, on cough, nociception and ventilation in the unanaesthetized guinea-pig","volume":"93","author":"Adcock","year":"1988","journal-title":"Br J Pharmacol"},{"key":"10.4065\/83.10.1116_bib76","first-page":"B1","article-title":"Hospices are growing venue for drug trials","author":"Rubinstein","year":"2007","journal-title":"The Wall Street Journal"},{"issue":"5","key":"10.4065\/83.10.1116_bib77","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/00000542-199711000-00011","article-title":"Opioid-sparing effects of a low-dose infusion of naloxone in patient-administered morphine sulfate","volume":"87","author":"Gan","year":"1997","journal-title":"Anesthesiology"},{"issue":"2","key":"10.4065\/83.10.1116_bib78","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0376-8716(98)00087-8","article-title":"Efficacy of orally administered methylnaltrexone in decreasing subjective effects after intravenous morphine","volume":"52","author":"Yuan","year":"1998","journal-title":"Drug Alcohol Depend"},{"issue":"21","key":"10.4065\/83.10.1116_bib79","doi-asserted-by":"crossref","first-page":"7552","DOI":"10.1073\/pnas.0802203105","article-title":"Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection","volume":"105","author":"Keele","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.4065\/83.10.1116_bib80","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1086\/529206","article-title":"HIV-1 variation before seroconversion in men who have sex with men: analysis of acute\/early HIV infection in the multicenter AIDS cohort study","volume":"197","author":"Gottlieb","year":"2008","journal-title":"J Infect Dis"},{"issue":"1","key":"10.4065\/83.10.1116_bib81","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1086\/338011","article-title":"Methadone enhances human immunodeficiency virus infection of human immune cells","volume":"185","author":"Li","year":"2002","journal-title":"J Infect Dis"},{"issue":"3","key":"10.4065\/83.10.1116_bib82","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1124\/jpet.103.056697","article-title":"Methylnaltrexone antagonizes opioid-mediated enhancement of HIV infection of human blood mononuclear phagocytes","volume":"307","author":"Ho","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.4065\/83.10.1116_bib83","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/hep.21470","article-title":"Hepatitis C virus eradication in intravenous drug users maintained with subcutaneous naltrexone implants","volume":"45","author":"Jeffrey","year":"2007","journal-title":"Hepatology"},{"issue":"4","key":"10.4065\/83.10.1116_bib84","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/00000542-200610000-00008","article-title":"Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis?","volume":"105","author":"Exadaktylos","year":"2006","journal-title":"Anesthesiology"},{"issue":"2","key":"10.4065\/83.10.1116_bib85","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/ALN.0b013e31817f5b73","article-title":"Anesthetic technique for radical prostatectomy surgery affects cancer recurrence: a retrospectivwe analysis","volume":"109","author":"Biki","year":"2008","journal-title":"Anesthesiology"},{"issue":"4","key":"10.4065\/83.10.1116_bib86","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cct.2008.01.002","article-title":"Can regional analgesia reduce the risk of recurrence after breast cancer? methodology of a multicenter randomized trial","volume":"29","author":"Sessler","year":"2008","journal-title":"Contemp Clin Trials"},{"issue":"15","key":"10.4065\/83.10.1116_bib87","first-page":"4491","article-title":"Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth","volume":"62","author":"Gupta","year":"2002","journal-title":"Cancer Res"},{"issue":"1\u20132","key":"10.4065\/83.10.1116_bib88","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.mvr.2006.04.004","article-title":"Methylnaltrexone inhibits opiate and VEGF-induced angiogenesis: role of receptor transactivation","volume":"72","author":"Singleton","year":"2006","journal-title":"Microvasc Res"},{"issue":"6","key":"10.4065\/83.10.1116_bib89","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1158\/1535-7163.MCT-07-2217","article-title":"Synergistic effects of methylnaltrexone with 5-fluorouracil and bevacizumab on inhibition of vascular endothelial growth factor-induced angiogenesis","volume":"7","author":"Singleton","year":"2008","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"10.4065\/83.10.1116_bib90","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1165\/rcmb.2006-0327OC","article-title":"Attenuation of vascular permeability by methylnaltrexone: role of mOP-R and S1P3 transactivation","volume":"37","author":"Singleton","year":"2007","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"10.4065\/83.10.1116_bib91","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.amjsurg.2006.01.001","article-title":"The contribution of opiate analgesics to the development of infectious complications in burn patients","volume":"192","author":"Schwacha","year":"2006","journal-title":"Am J Surg"},{"key":"10.4065\/83.10.1116_bib92","author":"Todar"},{"issue":"2","key":"10.4065\/83.10.1116_bib93","first-page":"171","article-title":"Morphine directly activates the virulence of Pseudomonas aeruginosa and enhances its barrier dysregulating effect against the epithelium [abstract A8]","volume":"7","author":"Zaborina","year":"2006","journal-title":"Surg Infect"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611606174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611606174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T05:56:02Z","timestamp":1738907762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611606174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":92,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0025619611606174"],"URL":"https:\/\/doi.org\/10.4065\/83.10.1116","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}